PGM
CUE icon

Parian Global Management’s Cue Biopharma CUE Stock Holding History

Parian Global Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-367
Closed -$93K – 47
2019
Q3 		$93K Buy
+367
New +$88.2K 0.04% 30

Other funds holding CUE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

Parian Global Management's CUE Position: Q4 2019 in Review

Parian Global Management sold out of Cue Biopharma (CUE) in Q4 2019, closing a stake of 367 shares — an estimated $93K sold.

Parian Global Management first reported a position in CUE in Q3 2019 and held it in 1 quarter. The position peaked at $93K in Q3 2019. 63 funds tracked by Wall St. Rank hold CUE as of Q4 2019.

  • Parian Global Management reported no remaining Cue Biopharma position as of Q4 2019 after selling out during the quarter.
  • Parian Global Management sold 367 Cue Biopharma shares in Q4 2019, an estimated $93K.
  • Parian Global Management first reported a position in Cue Biopharma in Q3 2019 and held it in 1 quarter.
  • Parian Global Management's Cue Biopharma position peaked at $93K in Q3 2019.
  • 63 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2019.

Based on Parian Global Management's 13F filing for Q4 2019, filed 14 Feb 2020.